Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ORG.one project - Whole genome sequencing of White-backed and Hooded Vultures Van der Meer, K.A. & Ottenburghs, J. (expected mid 2024)

ABSTRACT: Whole genome sequencing of White-backed and Hooded Vultures Van der Meer, K.A. & Ottenburghs, J. (expected mid 2024)

PROVIDER: PRJEB65321 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Homo sapiens isolate:embryo kideny | cultivar:van der Eb's lab

Project description:Homo sapiens isolate:embryo kideny | cultivar:van der Eb's lab Targeted Locus (Loci)

| PRJNA301174 | ENA

Expression data from MDS patients with der(1;7)(q10;p10)

Project description:Gene expression profiling was significantly different between der(1;7)(q10;p10) and -7/7q- patients by cluster analysis. There were total 1628 dysregulated genes in both der(1;7)(q10;p10) and -7/del(7q) cohorts.

2017-09-22 | GSE100340 | GEO

Genomic hybridization of Col, Van and reciprocal hybrids

Project description:Genomic DNA of Col, Van and reciprocal hybrids, bioprime random labeling, and hybridization to AtTILE1 forward array. Study on genetic ploymorphic between arabidopsis thaliana accessions Col-0 and Van-0, and set the scale of F1 hybrid intensity for SFPs.

2008-11-18 | GSE13620 | GEO

Gene expression of Col, Van and reciprocal hybrids

Project description:Gene expression of Col, Van and reciprocal hybrids using double-stranded cDNA followed by bioprime random labeling, and hybridization to AtTILE1 forward array. Study on gene expression polymorphism between arabidopsis thaliana accessions Col-0 and Van-0. Study on the inheritance of gene expression in reciprocal hybrids. Keywords: cDNA hybridization

2008-04-11 | GSE8891 | GEO

Darmkrebs: Chancen der Verhütung durch Screening (DACHS)

Project description:Darmkrebs: Chancen der Verhütung durch Screening (DACHS)

| PRJNA449797 | ENA

Indium-contacted van der Waals gap tunneling spectroscopy for van der Waals layered materials.

Project description:The electrical phase transition in van der Waals (vdW) layered materials such as transition-metal dichalcogenides and Bi2Sr2CaCu2O8+x (Bi-2212) high-temperature superconductor has been explored using various techniques, including scanning tunneling and photoemission spectroscopies, and measurements of electrical resistance as a function of temperature. In this study, we develop one useful method to elucidate the electrical phases in vdW layered materials: indium (In)-contacted vdW tunneling spectroscopy for 1T-TaS2, Bi-2212 and 2H-MoS2. We utilized the vdW gap formed at an In/vdW material interface as a tunnel barrier for tunneling spectroscopy. For strongly correlated electron systems such as 1T-TaS2 and Bi-2212, pronounced gap features corresponding to the Mott and superconducting gaps were respectively observed at T = 4 K. We observed a gate dependence of the amplitude of the superconducting gap, which has potential applications in a gate-tunable superconducting device with a SiO2/Si substrate. For In/10 nm-thick 2H-MoS2 devices, differential conductance shoulders at bias voltages of approximately ± 0.45 V were observed, which were attributed to the semiconducting gap. These results show that In-contacted vdW gap tunneling spectroscopy in a fashion of field-effect transistor provides feasible and reliable ways to investigate electronic structures of vdW materials.

| S-EPMC8423830 | biostudies-literature

Prunus avium cultivar:Van

Project description:Prunus avium cultivar:Van Raw sequence reads

| PRJNA481865 | ENA

Phase I/II Studie zum Einsatz von Capecitabin und Oxaliplatin (XELOX) in Kombination mit Bevacizumab und Imatinib in der Erstlinientherapie von Patienten mit fortgeschrittenem kolorektalem Karzinom

Project description:Primary objectives: Primäres Studienziel der Phase IDefinition der empfohlenen Dosis von Capecitabin und Oxaliplatin bei gleichzeitiger Therapie mit Bevacizumab und Imatinib. Primäres Studienziel der Phase IIMachbarkeit und Verträglichkeit der in der Phase I ermittelten Dosis der Kombination aus XELOX mit Bevacizumab und Imatinib anhand der Bestimmung der Sicherheit und der Nebenwirkungen und Toxizitäten der Kombinationstherapie. Primary endpoints: Phase I Definition der empfohlenen Dosis von Capecitabin und Oxaliplatin bei gleichzeitiger Therapie mit Imatinib und Bevacizumab. Phase II Bestimmung der Sicherheit und der Nebenwirkungen und Toxizitäten der Kombinationstherapie mit Capecitabin, Oxaliplatin, Imatinib und Bevacizumab

| 2521499 | ecrin-mdr-crc

Der-2

Project description:Drosophila melanogaster Der-2, Derlin-2, is differentially expressed in 13 experiment(s);

| FBgn0038438 | ExpressionAtlas

Der-1

Project description:Drosophila melanogaster Der-1, Derlin-1, is differentially expressed in 7 experiment(s);

| FBgn0267972 | ExpressionAtlas